Curated Wealth Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$152M Buy
1,407,435
+1,396,707
+13,019% +$36.5M 19.71% 1
2026
Q1
$301K Buy
+10,728
New +$286K 0.04% 156
2025
Q4
Sell
-8,289
Closed -$211K 219
2025
Q3
$211K Sell
8,289
-33,533
-80% -$828K 0.03% 148
2025
Q2
$1.01M Sell
41,822
-2,651
-6% -$61.8K 0.12% 56
2025
Q1
$1.13M Sell
44,473
-864
-2% -$22.6K 0.15% 45
2024
Q4
$1.2M Buy
45,337
+9,236
+26% +$251K 0.14% 42
2024
Q3
$1.04M Buy
36,101
+648
+2% +$18.9K 0.13% 45
2024
Q2
$992K Buy
+35,453
New +$976K 0.14% 44
2024
Q1
Sell
-28,426
Closed -$789K 234
2023
Q4
$818K Buy
28,426
+18,929
+199% +$572K 0.13% 56
2023
Q3
$315K Sell
9,497
-1,259
-12% -$44.5K 0.06% 102
2023
Q2
$395K Sell
10,756
-10,803
-50% -$420K 0.08% 81
2023
Q1
$880K Sell
21,559
-345
-2% -$14.9K 0.2% 38
2022
Q4
$1.12M Sell
21,904
-2,138
-9% -$103K 0.27% 32
2022
Q3
$1.05M Buy
24,042
+103
+0.4% +$5K 0.31% 27
2022
Q2
$1.25M Buy
23,939
+4,036
+20% +$206K 0.37% 23
2022
Q1
$1.18M Hold
19,903
0.4% 30
2021
Q4
$1.18M Buy
19,903
+15
+0.1% +$743 0.38% 31
2021
Q3
$855K Sell
19,888
-342
-2% -$15.2K 0.48% 36
2021
Q2
$792K Buy
20,230
+2,533
+14% +$98.5K 0.43% 38
2021
Q1
$641K Buy
17,697
+3,148
+22% +$112K 0.39% 46
2020
Q4
$535K Buy
+14,549
New +$534K 0.35% 54

Other funds holding PFE

Curated Wealth Partners's PFE Position: Q2 2026 in Review

Curated Wealth Partners increased its Pfizer (PFE) stake by 13,019% in Q2 2026, buying an estimated $36.5M and bringing the position to 1,407,435 shares worth $152M. The position accounts for 19.71% of the portfolio, ranked #1.

Curated Wealth Partners first reported a position in PFE in Q4 2020 and has held it in 21 quarters since. 991 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Curated Wealth Partners held 1,407,435 shares of Pfizer worth $152M as of Q2 2026.
  • Curated Wealth Partners bought 1,396,707 Pfizer shares in Q2 2026, an estimated $36.5M.
  • Pfizer made up 19.71% of Curated Wealth Partners's portfolio in Q2 2026, its #1 holding.
  • Curated Wealth Partners first reported a position in Pfizer in Q4 2020 and has held it in 21 quarters since.
  • 991 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.